VTRS
Viatris Inc
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$16.95
−1.05%Forward multiples
Based on analyst estimates
- P/E forward
- 6.67x
- P/E 2026E
- 6.75x
- P/E 2027E
- 6.37x
- P/E 2028E
- 5.90x
- P/S forward
- 1.31x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.37x
- Price / sales
- 1.32x
- Price / cash flow
- 8.35x
Enterprise value
- Enterprise value
- $31.6B
- EV / sales
- 2.14x
- EV / EBITDA
- 11.96x
- EV / EBIT
- -361.79x
- Market cap
- $19.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026